companydata.dkEir Diagnostics ApS: Financial statements 2023
CVR: 40339396
Eir Diagnostics ApS (CVR 40339396) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,060,807 and a net result of DKK -507,135 compared with DKK -593,972 the year before. That is a decrease of 36.1% compared with the year before. Equity amounted to DKK 7,562,266. The solvency ratio was 60.2%. The company had 3 employees in the financial year.
- Gross Profit
- 1,060,807 kr.
- Profit/Loss
- -507,135 kr.
- Equity
- 7,562,266 kr.
- Total Assets
- 12,565,806 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.1 mio. | -507 t. | 7.6 mio. | 3 |
| 2022 | - | 1.7 mio. | -594 t. | 7.6 mio. | 4 |
| 2021 | - | 1.2 mio. | -469 t. | 7.4 mio. | - |
| 2020 | - | 1.5 mio. | -369 t. | 5.2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of September 1, 2023, Michael Niels Døssing has stepped down as director of Eir Diagnostics ApS.
Eir Diagnostics ApS has published its annual report for 2022. Gross profit came to DKK 1,661,104, and the net result was DKK -593,972.
As of March 30, 2023, Tine Walldén Jespersen has joined the board of directors of Eir Diagnostics ApS.
As of March 30, 2023, Kasper Hansen has joined the board of directors of Eir Diagnostics ApS.
As of March 30, 2023, Tine Walldén Jespersen is registered as adm. dir. of Eir Diagnostics ApS.
As of March 29, 2023, Tine Walldén Jespersen has left the board of directors of Eir Diagnostics ApS.
As of March 29, 2023, Kasper Hansen has left the board of directors of Eir Diagnostics ApS.
As of March 29, 2023, Tine Walldén Jespersen has stepped down as director of Eir Diagnostics ApS.
About Eir Diagnostics ApS
Eir Diagnostics ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named AptaZense ApS. The management consists of Tine Walldén Jespersen. The company's owners include Danmarks Tekniske Universitet, KEMPHANSEN HOLDING ApS and PLASTISENS ApS. In 2025, the company reported a gross profit of DKK 370,098 and a net result of DKK -16,645,537 compared with DKK -455,658 the year before. Equity amounted to DKK -4,205,596.